| ［1］ |
Guo Y，Wang J，Wu W，et al. Incidence of ischemia reperfusion injury related biliary complications in liver transplantation: effect of different types of donors［J］.Transplant Proc，2022，54（7）:1865-1873.
|
| ［2］ |
Rossi AF，Grosso C，Zanasi G，et al. Endoscopic management of biliary complications after orthotopic liver transplantation［J］.Gastroenterology，1998，114:A538.
|
| ［3］ |
Michael FA，Friedrich-rust M，Erasmus HP，et al. Treatment of nonanastomotic biliary strictures after liver transplantation: how effective is our current treatment strategy？［J］. J Clin Med，2023，12（10）:3491.
|
| ［4］ |
Liao M，Guo H，Tong G，et al. Can ultrasonography differentiate anastomotic and non-anastomotic biliary strictures after orthotopic liver transplantation-a single-center experience［J］. Eur J Radiol，2021，134:109416.
|
| ［5］ |
杨扬，王金锐，郑荣琴，等. 中国大陆地区肝移植后缺血性胆道病变诊断及治疗专家共识［J］. 器官移植，2015，1（1）:1-5.
|
| ［6］ |
Ren J，Lu MD，Zheng RQ，et al. Evaluation of the microcirculatory disturbance of biliary ischemia after liver transplantation with contrast-enhanced ultrasound: preliminary experience［J］. Liver Transpl，2009，15（12）:1703-1708.
|
| ［7］ |
Ren J，Zheng BW，Wang P，et al. Reveal ingimpaired blood supply to the bile ducts on contrast-enhanced ultrasound: a novel diagnosis method to ischemic-type biliary lesions after orthotropic liver transplantation［J］. Ultrasound Med Biol，2013，39（5）:753-760.
|
| ［8］ |
Xu YB，Min ZG，Jiang HX，et al. Diagnostic value of magnetic resonance cholangiopancreatography for biliary complications in orthotopic liver transplantation: a meta-analysis［J］. Transplant Proc，2013，45（6）:2341-2346.
|
| ［9］ |
Kinner S，Schubert TB，Said A，et al. Added value of gadoxetic acidenhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications［J］. Eur Radiol，2017，27（10）:4415-4425.
|
| ［10］ |
Wang J，Liu JJ，Liang YY，et al. Could diffusion-weighted imaging detect injured bile ducts of ischemic-type biliary lesions after orthotopic liver transplantation？［J］. Am J Roentgenol，2012，199（4）:901-906.
|
| ［11］ |
Boraschi P，Donati F，Pacciardi F，et al. Biliary complications after liver transplantation: assessment with MR cholangiopancreatography and MR imaging at 3T device［J］. Eur J Radiol，2018，106: 46-55.
|
| ［12］ |
Urbani l，Mazzoni A，Bianco I，et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients［J］. J Clin Apher，2008，23（2）:55-62.
|
| ［13］ |
Farid WR，De Jonge J，Zondervan PE，et al. Relationship between the histological appearance of theportal vein and development of ischemic-type biliary lesions after liver transplantation［J］. Liver Transpl，2013，19（10）:1088-1098.
|
| ［14］ |
Seehofer D，Rayes N，Tullius SG，et al. CMV hepatitis after liver transplantation: incidence，clinical course，and long-term followup［J］. Liver Transpl，2002，8（12）:1138-1146.
|
| ［15］ |
Dubbeld J，Hoekstra H，Farid W，et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors［J］.Br J Surg，2010，97（5）:744-753.
|
| ［16］ |
Suárez F，Otero A，Solla M，et al. Biliary complications after liver transplantation from maastrichtcategory-2 non-heart-beating donors［J］. Transplantation，2008，85（1）:9-14.
|
| ［17］ |
Hessheimer AJ，Cárdenas A，García-valdecasas JC，et al. Can we prevent ischemic-type biliary lesions in donation after circulatory determination of death liver transplantation？［J］. Liver Transpl，2016，22（7）:1025-1033.
|
| ［18］ |
Durán M，Calleja R，Hann A，et al. Machine perfusion and the prevention of ischemic type biliary lesions following liver transplant:what is the evidence？［J］. World J Gastroenterol，2023，29（20）:3066-3083.
|
| ［19］ |
Gastaca M，Guerra M，Alvarez martinez L，et al. Octogenarian donors in liver transplantation［J］. Transplant Proc，2016，48（9）:2856-2858.
|
| ［20］ |
Firl DJ，Hashimoto K，O'rourke C，et al. Impact of donor age in liver transplantation from donation after circulatory death donors:a decade of experience at Cleveland Clinic［J］. Liver Transpl，2015，21（12）:1494-1503.
|
| ［21］ |
Giannella M，Freire M，Rinaldi M，et al. Development of a risk prediction model for carbapenem-resistant Enterobacteriaceae infection after liver transplantation: a multinational cohort study［J］.Clin Infect Dis，2021，73（4）:e955-966.
|
| ［22］ |
Heidenhain C，Pratschke J，Puhl G，et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation［J］. Transpl Int，2010，23（1）:14-22.
|
| ［23］ |
Sanchez-urdazpal L，Gores GJ，Ward EM，et al. Clinical outcome of ischemic-type biliary complications after liver transplantation［J］.TransplantProc，1993，25（1 pt 2）:1107-1109.
|
| ［24］ |
Guichelaar MM，Benson JT，Malinchoc M，et al. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation［J］. Am J Transplant，2003，3（7）:885-890.
|
| ［25］ |
Chan EY，Olson LC，Kisthard JA，et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors［J］. Liver Transpl，2008，14（5）:604-610.
|
| ［26］ |
Abt PL，Desai NM，Crawford MD，et al. Survival following liver transplantation from non-heart-beatingdonors［J］. Ann Surg，2004，239（1）:87-92.
|
| ［27］ |
Lee KW，Simpkins CE，Montgomery RA，et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors［J］. Transplantation，2006，82（12）:1683-1688.
|
| ［28］ |
de vera ME，Lopez-solis R，Dvorchik I，et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center［J］. AmJ Transplant，2009，9（4）:773-781.
|
| ［29］ |
Shcherba A，Kuzmenkova LL，Efimov DJ，et，al. Risk factors and prediction of bacterial complications in liver transplantation［J］. HPB Surg，2023，28（3）:10-20.
|
| ［30］ |
Cherchi V，Vetrugno L，Zanini V，et al. Association between indocyanine green clearance testand ischemic type biliary lesions within one year after orthotopic liver transplantation［J］. Gastroenterol Hepatol，2021，44（10）:687-695.
|
| ［31］ |
Stewart ZA，Cameron AM，Singer AL，et al. Histidine-tryptophanketoglutarate （HTK） is associated with reduced graft survival in deceased donor livers，especially those donated after cardiac death［J］.Am J Transplant，2009，9（2）:286-293.
|
| ［32］ |
Adam R，Delvart V，Karam V，et al. Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry［J］. Am J Transplant，2015，15（2）:395-406.
|
| ［33］ |
Lembach jahnsen H，Mergental H，Pereramtpr，et al. Ex-situ liver preservation with machine preservation［J］. Curr Opin Organ Transplant，2021，26（2）:121-132.
|
| ［34］ |
Dries SOD，Sutton ME，Karimian N，et al. Hypothermic oxygenated machine perfusion prevent sarteriolonecrosis of the peribiliary plexus in pig livers donated after circulatory death［J］. PLoS One，2014，9（2）:e88521.
|
| ［35］ |
Panayotova G，Lunsford K，Quillin R，et al. Portable hypothermic oxygenated machine perfusion fororgan preservation in liver transplantation: a randomized，open-label，clinical trial［J］.Hepatology，2024，79（5）:1033-1047.
|
| ［36］ |
Chen WJ，Ying DJ，Liu ZJ，et al. Analysis of the arterial supply of the extrahepatic bile ducts and its clinical significance［J］. Clin Anat，1999，12（4）:245-249.
|
| ［37］ |
Ramos P，Williams P，Salinas J，et al. Abdominal organ preservation solutions in the age of machine perfusion［J］. Transplantation，2023，107（2）:326-340.
|
| ［38］ |
Saitta B，Edgington J，Hart T，et al. Application of an external fixator vascular compressor （EFVC） in the critically injured trauma patient:a novel damage control technique［J］. Eur J Orthop Surg Traumatol，2019，29（6）:1337-1345.
|
| ［39］ |
Abbenante D，Raone B，Baraldi C，et al. Angiokeratoma circumscriptum naeviforme presenting as a dark warty plaque on the leg［J］. Acta Dermatovenerol Croat，2021，29（3）:169-170.
|
| ［40］ |
Lou Z. Massive presacral bleeding during rectalsurgery: from anatomy to clinical practice［J］. World J Gastroenterol，2013，19（25）:4039.
|
| ［41］ |
Hashimoto K，Eghtesad B，Gunasekaran G，et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors［J］. Am J Transplant，2010，10（12）:2665-2672.
|
| ［42］ |
Burlage LC，Karangwa SA，Lisman T，et al. Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors［J］. Liver Transpl，2015，21（9）:1231-1232.
|
| ［43］ |
Bang JB，Kim BW，Kim YB，et al. Risk factor for ischemictype biliary lesion after ABO-incompatible living donor liver transplantation［J］. World J Gastroenterol，2016，22（30）:6925-6935.
|
| ［44］ |
Zhang YC，Liu W，Fu BS，et al. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation［J］. Cytotherapy，2017，19（2）:194-199.
|
| ［45］ |
Egawa H，Teramukai S，Haga H，et al. Present status of ABOincompatible living donor liver transplantation in Japan［J］.Hepatology，2008，47（1）:143-152.
|
| ［46］ |
Zhang Y，Zhang J，Yi H，et al. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phaseⅠ/Ⅱrandomized，open-label，controlled trial［J］. Stem Cell Res Ther，2021，12（1）:244.
|
| ［47］ |
Lee TB，Ko HJ，Shim JR，et al. ABO-incompatible living donor liver transplantation with a simplified desensitization and immunosuppression protocol: a single-center retrospective study［J］.Exp ClinTransplant，2021，19（7）:676-685.
|
| ［48］ |
Nemes B，Gámán G，Doros A. Biliary complications after liver transplantation［J］. Expert RevGastroenterol Hepatol，2015，9（4）:447-466.
|
| ［49］ |
Shagrani M，Kumar K，Baker A，et al. ABO-incompatible pediatric liver transplantation with antibody and B-cell depletion-free immunosuppressive protocol inhigh consanguinity communities［J］.Transplant Direct，2022，8（12）:e1353.
|
| ［50］ |
Zorzetti N，Lauro A，Khouzam S，et al. Immunosuppression，compliance，and tolerance after orthotopic liver transplantation: state of the art［J］. Exp Clin Transplant，2022，20（suppl 1）:3-9.
|
| ［51］ |
Wang W，Zheng S，Shong Z，et al. Development of a guinea pig model of perinatal cytomegalo virus-induced hepatobiliary injury［J］.Fetal Pediatr Pathol，2011，30（5）:301-311.
|
| ［52］ |
Engelmann C，Sterneck M，Weiss KH，et al. Prevention and management of CMV infections after liver transplantation: current practice in German transplant centers［J］. J Clin Med，2020，9（8）:2352.
|
| ［53］ |
Razonable RR. Cytomegalovirus infection after liver transplantation:current concepts and challenges［J］. World J Gastroenterol，2008，14（31）:4849-4860.
|
| ［54］ |
Lautenschlager I. CMV infection，diagnosis and antiviral strategies after liver transplantation［J］. TransplInt，2009，22（11）:1031-1040.
|
| ［55］ |
Razonable RR，Humar A. Cytomegalovirus insolid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice［J］. Clin Transplant，2019，33（9）:e13512.
|
| ［56］ |
Tang JX，Zhang K，Fang TS，et al. Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus［J］. World J Gastroenterol，2023，29（11）:1745-1756.
|
| ［57］ |
Kienlein S，Schoening W，Andert A，et al. Biliary complications in liver transplantation: impact of anastomotic technique and ischemic time on short- and long-term outcome［J］. World J Transplant，2015，5（4）:300-309.
|
| ［58］ |
He L，Fu Z，Wang M，et al. Prevention and treatment of carbapenemresistant organism bacilli from liver transplantation donors-single center experience［J］. Infect Drug Resist，2022，15: 47-52.
|
| ［59］ |
Kamal SM，Wahed A，Abdelhakam S. Role of ERCP in management of bacterial cholangitis in living-donor liver transplant recipients with biliary complications: a single center study［J］. J Egyptian Soc Parasitol，2023，53:219-225.
|
| ［60］ |
Magro B，Tacelli M，Mazzola A，et al. Biliary complications after liver transplantation: current perspectives and future strategies［J］.Hepatobiliary Surg Nutr，2021，10（1）:76-92.
|
| ［61］ |
Sharma S，Gurakar A，Jabbour N. Biliary strictures following liver transplantation: past，present and preventive strategies［J］. Liver Transpl，2008，14（6）:759-769.
|
| ［62］ |
Park H，Han ES，Park SJ，et al. Anatomical classification and clinical outcomes of biliary stricturesin living donor liver transplantation using right liver grafts［J］. Liver Transplant，2022，29（3）:307-317.
|
| ［63］ |
Sheng R，Ramirez CB，Zajko AB，et al. Biliary stones and sludge in liver transplant patients: a 13-yearexperience［J］. Radiology，1996，198（1）:243-247.
|
| ［64］ |
Katariya N，Mathur AK. Biliary strictures: a surgeon's perspective for interventional radiologists［J］. Semin Intervent Radiol，2021，38（3）:273-279.
|
| ［65］ |
Seehofer D，Eurich D，Veltzke-schliekerw，et al. Biliary complications after liver transplantation: old problems and new challenges［J］. Am J Transplant，2013，13（2）:253-265.
|
| ［66］ |
Saleem A，Baron TH，Gostout CJ，et al. Endoscopic retrograde cholangiopancreatography using a single-balloon enteroscope in patients with altered Roux-en-Y anatomy［J］. Endoscopy，2010，42（8）:656-660.
|
| ［67］ |
Zoepf T，Maldonado de dechêne EJ，Dechêne A，et al. Optimized endoscopic treatment of ischemic-type biliary lesions after liver transplantation［J］. Gastrointest Endosc，2012，76（3）:556-563.
|
| ［68］ |
Ferreira MTGB，Ribeiro IB，De moura DTH，et al. Stent versus balloon dilation for the treatment of dominant strictures in primary sclerosing cholangitis: a systematic review and meta-analysis［J］. Clin Endosc，2021，54（6）:833-842.
|
| ［69］ |
Yan KL，Gomes AS，Monteleone PA，et al. Management of biliary stricture in pediatric liver transplantation patients: long-term outcomes［J］. Liver Transpl，2021，27（12）:1788-1798.
|
| ［70］ |
Valentino PL，Wang T，Shabanova V，et al. North American biliary stricture management strategiesin children after liver transplantation: a multicenter analysis from the society of pediatric liver transplantation（SPLIT） registry［J］. Liver Transpl，2022，28（5）:819-833.
|
| ［71］ |
Buis CI，Hoekstra H，Verdonk RC，et al. Causesand consequences of ischemic-type biliary lesions after liver transplantation［J］. J Hepatobiliary Pancreat Surg，2006，13（6）:517-524.
|
| ［72］ |
Chen Z，Ju W，Chen C，et al. Application of various surgical techniques in liver transplantation: a retrospective study［J］. Ann Transl Med，2021，9（17）:1367.
|
| ［73］ |
Schlitt HJ，Meier PN，Nashan B，et al. Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation［J］. Ann Surg，1999，229（1）:137-145.
|
| ［74］ |
Dubbeld J，Van hoek B，Ringers J，et al. Biliary complications after liver transplantation from donation after cardiac death donors:an analysis of risk factors and long-term outcome from a single center［J］. Ann Surg，2015，261（3）:e64.
|
| ［75］ |
Belli LS，Duvoux C，Artzner T，et al. Liver transplantation for patients with acute-on-chronic liver failure （ACLF） in Europe: results of the ELITA/EF-CLIF collaborative study （ECLIS）［J］. J Hepatol，2021，75（3）:610-622.
|